Resultados de la búsqueda 31-40 of 3925 for Jardiance 10 mg
... mg/m2; Cycles 2-6: 500 mg/m2). Patients ... (10) advanced, unresectable multiple myeloma. Also ... 10 g/dL, a neutrophil count ≥ 1,500 /microliter ...
A selected subset of participants (10 survivors and 10 ... Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg ... mg/m2; Cycles 2-6: 500 ...
Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. Inotuzumab attaches to cancer cells in ...
Dosing will begin with the (Z)-endoxifen 40 mg/day dose and may additionally explore either a lower (20 mg/day) or higher (80 mg/day) dose level based on ...
The purpose of this study is to compare disease-free survival (DFS) of patients with high-risk cutaneous squamous cell carcinoma (CSCC) treated with adjuvant ...
In Part 2 Cohort 2, a safety run in and expansion phase will be undertaken with Q901 at the RP2D administered in combination with pembrolizumab (400 mg Q6W) in ...
A selected subset of participants (10 survivors and 10 caregivers) will be ... Patients will be randomized in a 1:1 ratio to receive either alectinib, 600 mg ...
Patients randomized to B+R will receive 6 cycles of treatment consisting of a rituximab infusion (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2) on Day 1 and ...
Page 1.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?